Survey: China, Malaysia demonstrate strong pharma growth

05/14/2013 | BioSpectrum Asia · BioSpectrum Asia

Despite slowing fiscal growth in China, government investments are ensuring that the country's pharmaceutical industry will continue to expand and attract private investment. Malaysia, too, is rapidly becoming a center of pharmaceutical and medical device manufacturing, with estimates that the medtech market there will hit $2.8 billion in four years. The assessments of both countries come from the BioSpectrum Asia Top 20 Survey.

View Full Article in:

BioSpectrum Asia · BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC